SAMEEKSHA PATIL NG-A-KIEN: Open Payments
NPI 1407388382 · DELRAY BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$787 in 19 payments from 9 companies in 2025. Trend: 2023 $294 · 2024 $798 · 2025 $787
Food & beverage: $787
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 3 | $256 |
| Optinose US, Inc. | 3 | $150 |
| Regeneron Healthcare Solutions, Inc. | 6 | $143 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $120 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Medtronic, Inc. | 1 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Phadia US Inc. | 1 | $15 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: DUPIXENT, Xhance, XIFAXAN, NUCALA, PROPEL, FASENRA, ImmunoCAP, NEFFY.
Industry payments across FL — which companies pay providers there.
